Clinical Trials Browser

Phase 2 × Breast Neoplasms × onartuzumab × Clear all

NCT01186991 2017-01-20

Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast Cancer

Phase 2 Completed

Breast Neoplasms